Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker

被引：0
|
作者：
Yumei Tang
Ye Lei
Peng Gao
Junting Jia
Huijun Du
Qitong Wang
Zhixin Yan
Chen Zhang
Guojun Liang
Yanfeng Wang
Weijun Ma
Nianzeng Xing
Le Cheng
Laifeng Ren
机构：
[1] Dali University,School of Basic Medical Sciences
[2] Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University,Department of Immunology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital
[3] Shanxi Keda Research Institute,Department of Urology
[4] National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Department of Urology, Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital
[5] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Pharmacy, Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital
[6] Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University,Department of Cardiology
[7] BGI-Shenzhen,undefined
[8] Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University,undefined
[9] the Fourth Affiliated Hospital of Harbin Medical University,undefined
[10] Shanxi Beike Biotechnology Co.,undefined
[11] Ltd,undefined
[12] BGI-Yunnan,undefined
来源：
BMC Cancer | / 23卷
关键词：
Cancers; Biomarker; Immune infiltration; Immunotherapy; Genomic instability;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker
    Tang, Yumei
    Lei, Ye
    Gao, Peng
    Jia, Junting
    Du, Huijun
    Wang, Qitong
    Yan, Zhixin
    Zhang, Chen
    Liang, Guojun
    Wang, Yanfeng
    Ma, Weijun
    Xing, Nianzeng
    Cheng, Le
    Ren, Laifeng
    BMC CANCER, 2023, 23 (01)
  • [2] Pan-Cancer Analysis and Experimental Validation of SOX4 as a Potential Diagnosis, Prognosis, and Immunotherapy Biomarker
    Deng, Xinna
    Wang, Yashu
    Guo, Hao
    Wang, Qian
    Rao, Shuting
    Wu, Haijiang
    CANCERS, 2023, 15 (21)
  • [3] Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy
    Ma, Chao
    Zheng, Qiming
    Wang, Yepeng
    Li, Guoxiang
    Zhao, Mengmeng
    Sun, Zhigang
    AGING-US, 2023, 15 (17): : 8664 - 8691
  • [4] ADAM15 as a potential biomarker for pan-cancer prognosis and immunotherapy: Validation in HCC
    Guo, W.
    Liu, Y.
    Fan, L.
    Chen, B.
    ANNALS OF ONCOLOGY, 2024, 35
  • [5] Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy
    Cui, Zhiwei
    Zou, Fan
    Wang, Rongli
    Wang, Lijun
    Cheng, Feiyan
    Wang, Lihui
    Pan, Rumeng
    Guan, Xin
    Zheng, Nini
    Wang, Wei
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [6] Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy
    Zhiwei Cui
    Fan Zou
    Rongli Wang
    Lijun Wang
    Feiyan Cheng
    Lihui Wang
    Rumeng Pan
    Xin Guan
    Nini Zheng
    Wei Wang
    World Journal of Surgical Oncology, 21
  • [7] DHX34 as a promising biomarker for prognosis, immunotherapy and chemotherapy in Pan-Cancer: A Comprehensive Analysis and Experimental Validation
    Liu, Nanbin
    Wang, Qian
    Zhu, Pengpeng
    He, Gaixia
    Li, Zeyu
    Chen, Ting
    Yuan, Jianing
    La, Ting
    Tian, Hongwei
    Li, Zongfang
    JOURNAL OF CANCER, 2024, 15 (20): : 6594 - 6615
  • [8] Pan-cancer analysis and KNSTRN as a potential prognosis biomarker
    Xiao, Shanshan
    Zou, Yuqing
    Wang, Li
    Wang, Qian
    Wang, Tao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
    Hu, Jian
    Qiu, Dongxu
    Yu, Anze
    Hu, Jiao
    Deng, Hao
    Li, Huihuang
    Yi, Zhenglin
    Chen, Jinbo
    Zu, Xiongbing
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] EXO1 as a potential biomarker for prognosis, immune infiltration, and immunotherapy in pan-cancer analysis
    Jikang Wang
    Fubo Wang
    Haoxuan Huang
    Functional & Integrative Genomics, 2025, 25 (1)
12345